Skip to main content

Table 1 Effect of ENX on baseline body weight, heart weight and the ratio of the heart to body weight

From: Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis

Group

Baseline BW(g)

Terminal BW (g)

Heart weight (g)

Heart/BW

Control n = 7

196 ± 10

205 ± 8

0.83 ± 0.054

4.1 ± 0.23

DOX n = 6

202 ± 14

177 ± 12

0.65 ± 0.278a

3.7 ± 0.21

ENX plus DOX n = 6

216 ± 10

194 ± 5

0.71 ± 0.25

3.6 ± 0.10

  1. BW body weight. Data is expressed as mean ± SEM. a P ≤ 0.05 for DOX vs. control (analyzed by one-way ANOVA followed by Fisher’s least significant difference (LSD) test)
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us